Navigation Links
ThermoGenesis Introduces New Cell Separation Technology for Veterinary Use at Major Equine Convention
Date:12/10/2008

RANCHO CORDOVA, Calif., Dec. 10 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that the Company has introduced a new line of veterinary point-of-care (POC) products under the Vantus brand. Unveiling of the first product, Res-Q60v ePRP, is taking place at this week's 54th Annual Convention of the American Association of Equine Practitioners (AAEP).

The initial product offering, Res-Q60v ePRP will be used for producing equine platelet-rich plasma (PRP) from 60 mL of blood. PRP is being used to treat ligament and tendon injuries in performance horses. The device enables veterinarians to prepare high quality PRP at the point-of-care in less than 15 minutes. The Company plans to introduce Res-Q60v eBMC, another equine product for producing high quality bone marrow concentrate, during calendar 2009. Many performance horses suffer orthopedic injuries and these biological products are emerging as a new means for the treatment to expedite healing of injured ligaments and tendons.

"We have been looking forward to launching the Res-Q60v ePRP at this prestigious equine industry event and commencing commercial sales in the early part of next year. The response among AAEP attendees was favorable and we look forward to participating in the veterinary market as an additional source of revenue for the company," said Matthew Plavan, Chief Executive Officer of ThermoGenesis.

"We appreciate the collaborative efforts with the University of California, Davis, School of Veterinary Medicine who consulted with us in our development of this technology specifically for equine applications," Plavan added.

"PRP delivers a high concentration of growth factors to damaged tissue where they
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. ThermoGenesis Corp. Provides Updated Information for Conference Call/Webcast to Discuss Management Transition
2. ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition
3. ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones
4. ThermoGenesis Reports First Quarter 2009 Results
5. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
6. ThermoGenesis Announces Filing of 510(k) Application for MarrowXpress
7. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
8. ThermoGenesis Corp. Reports First Quarter 2008 Results
9. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
10. Avon-ISI Launches New Web Site, Toll-free Technical Support Line; Introduces ISI as Fire Market Brand
11. Newport Introduces More Resources for Spanish Speaking Plan Participants
Post Your Comments:
*Name:
*Comment:
*Email: